Yichang Hec Changjiang Pharmaceutical Co., Ltd. has released a joint announcement with Sunshine Lake Pharma Co., Ltd., providing a monthly update on the proposed merger by absorption. This transaction involves the privatization of Yichang Hec Changjiang Pharmaceutical Co., Ltd. by Sunshine Lake Pharma Co., Ltd. The companies are progressing with the fulfillment of a pre-condition necessary for the merger. Zhang Yingjun, Chairman of Sunshine Lake Pharma, and Tang Xinfa, Chairman of Yichang Hec Changjiang Pharmaceutical, signed off on the announcement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information contained therein.